Psoriasis affects 2–3% of the global population — about 7.5 million Americans — causing chronic, uncomfortable, and often stigmatizing skin plaques. While conventional phototherapy (UVB, PUVA) has been used for decades, red and near-infrared light therapy offers an important distinction: it provides anti-inflammatory and tissue-healing benefits without the DNA-damaging effects of UV radiation.

How Psoriasis Develops and Why RLT May Help

Psoriasis is driven by an overactive immune response that accelerates skin cell turnover — normal skin renews every 28–30 days; psoriatic skin can renew in as few as 3–5 days, creating the characteristic thick, scaly plaques. RLT addresses several contributing mechanisms:

  • Reduced Th17 and Th1 inflammatory cytokines — These immune signals drive psoriatic inflammation; RLT modulates them downward
  • Anti-proliferative effect on keratinocytes — Slows the runaway skin cell multiplication
  • Improved barrier function — Supports repair of the disrupted skin barrier in psoriatic lesions
  • Reduced TNF-α — The same cytokine targeted by biologic drugs like Humira; RLT reduces it via different mechanisms
  • Reduced pruritus (itch) — Anti-inflammatory effects calm the nerve fibers driving the itch-scratch cycle

What the Research Shows

A 2011 study in Photomedicine and Laser Surgery found that 630 nm red light reduced psoriatic plaque thickness, scaling, and redness over 12 treatment sessions. A more recent 2022 review concluded that photobiomodulation was a safe and effective adjunct therapy for psoriasis, with most trials showing 30–50% improvements in PASI (Psoriasis Area and Severity Index) scores.

It's important to distinguish RLT from narrowband UVB phototherapy — both use light but completely different wavelengths with different mechanisms. RLT is safer for home use and avoids the skin cancer risk associated with long-term UV exposure.

RLT vs. UV Phototherapy for Psoriasis

UV phototherapy is more established and often produces faster clearing. RLT is safer for home use, has no skin cancer risk, and may complement UV therapy. For scalp psoriasis and areas hard to reach with clinical phototherapy, RLT provides accessible treatment options.

Practical Protocol for Psoriasis

Apply 630–660 nm red light and 830–850 nm NIR to affected areas. For plaques on body: position a panel at 6–12 inches. For scalp psoriasis: use a handheld device on the scalp. Sessions of 15–20 minutes, 4–5 times per week. Results are gradual — expect 8–16 weeks before significant plaque reduction. Consistency is key; psoriasis is a chronic condition requiring ongoing management.